DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 30 SEPTEMBER 2026

French public limited company (société anonyme)
with a share capital of €1,470,559,215.00
Registered office : 1973, boulevard de la Défense
92000 Nanterre – France
552 037 806 RCS Nanterre
www.vinci.com
DISCLOSURE
OF THE NUMBER OF SHARES FORMING THE CAPITAL
AND OF THE TOTAL NUMBER OF VOTING RIGHTS
AS OF 30 SEPTEMBER 2026
| Total number of shares | 588,223,686 |
| Theoretical number of voting rights (including treasury stock) |
588,223,686 |
| Number of voting rights (excluding treasury stock) | 551,548,982 |
This disclosure is on VINCI website www.vinci.com
(section: Finance/Investors/Regulatory information/7. Monthly information concerning the total number of voting rights and shares that make up the company’s capital)
Attachment
Publication Partner: ZM Newswire – Powered By Zeest Media
This press release is provided by the issuer. The statements and opinions expressed are those of the author and do not necessarily reflect the views of Zeest Media.
© 2026 Zeest Media. All rights reserved.
![Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026](https://dev.zeestmedia.com/wp-content/uploads/2026/10/perspective-therapeutics-inc-logo.jpg)
